# LORA-PITA IV General Investigation

> **NCT03905798** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 206 (actual)

## Conditions studied

- Status Epilepticus

## Interventions

- **DRUG:** Lorazepam

## Key facts

- **NCT ID:** NCT03905798
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-18
- **Primary completion:** 2023-11-15
- **Final completion:** 2023-11-15
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03905798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03905798, "LORA-PITA IV General Investigation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03905798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*